HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
54:@0.083944:0.033217:0.104640:0.033217:0.104640:0.013052:0.083944:0.013052:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
require thyroid-hormone replacement at a dosage of :@0.076190:0.084931:0.485130:0.084931:0.485130:0.069149:0.076190:0.069149:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.006410:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.005020:0.009223:0.009903:0.004551:0.014182:0.009903:0.009223:0.009827:0.006395:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.006410:0.010326:0.005125:0.006410:0.010326:0.006426:0.010357:0.009903:0.005866:0.010326:0.010175:0.009827:0.006410:0.009903:0.004747:0.004188
1.6  μg/kg  body  mass/day,  but  the  range  of  dosages :@0.076190:0.099352:0.485130:0.099352:0.485130:0.083569:0.076190:0.083569:0.008376:0.004188:0.008376:0.004188:0.002782:0.009223:0.010175:0.006607:0.007590:0.010175:0.004188:0.002767:0.010311:0.009903:0.010357:0.008104:0.004188:0.002767:0.014182:0.010326:0.005866:0.005866:0.006607:0.010357:0.010326:0.008104:0.004188:0.004188:0.002782:0.010311:0.009192:0.005125:0.004188:0.002767:0.005125:0.009223:0.009827:0.004188:0.002767:0.004551:0.010326:0.009223:0.010175:0.009827:0.004188:0.002767:0.009903:0.004747:0.004188:0.002767:0.010357:0.009903:0.005866:0.010326:0.010175:0.009827:0.005866:0.004188
is  wide,  and  may  vary  from  50  to  200  μg  per  day  to :@0.076190:0.113772:0.485130:0.113772:0.485130:0.097989:0.076190:0.097989:0.003024:0.005866:0.004188:0.002797:0.012564:0.003024:0.010357:0.009827:0.004188:0.004188:0.002797:0.010326:0.009223:0.010357:0.004188:0.002797:0.014182:0.010326:0.008104:0.004188:0.002797:0.008376:0.010326:0.004551:0.008104:0.004188:0.002797:0.004747:0.004551:0.009903:0.014182:0.004188:0.002797:0.008376:0.008376:0.004188:0.002797:0.005125:0.009903:0.004188:0.002797:0.008376:0.008376:0.008376:0.004188:0.002812:0.009223:0.010175:0.004188:0.002797:0.010311:0.009827:0.004551:0.004188:0.002797:0.010357:0.010326:0.008104:0.004188:0.002797:0.005125:0.009903:0.004188
achieve euthyroid status.  Recommended starting dos-:@0.076190:0.128192:0.480947:0.128206:0.480947:0.112423:0.076190:0.112409:0.010326:0.009782:0.009223:0.003024:0.009827:0.008376:0.009827:0.003704:0.009827:0.009192:0.005125:0.009223:0.008104:0.004536:0.009903:0.003024:0.010357:0.003689:0.005866:0.005125:0.010326:0.005125:0.009192:0.005866:0.004188:0.009726:0.003689:0.009177:0.009827:0.009782:0.009903:0.014182:0.014182:0.009827:0.009223:0.010357:0.009827:0.010357:0.003689:0.005866:0.005125:0.010326:0.004551:0.005125:0.003024:0.009223:0.010175:0.003689:0.010357:0.009903:0.005866:0.686375
17:@0.258956:0.122907:0.268672:0.122907:0.268672:0.113753:0.258956:0.113753:0.004858:0.004858
age of T4 replacement is listed in Table 3.:@0.076195:0.142626:0.376353:0.142626:0.376353:0.126844:0.076195:0.126844:0.010326:0.010175:0.009827:0.004188:0.009903:0.004747:0.004188:0.006441:0.008376:0.004188:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.003024:0.005866:0.004188:0.003024:0.003024:0.005866:0.005125:0.009827:0.010357:0.004188:0.003024:0.009223:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.004188:0.008376:0.004188
18:@0.376334:0.137332:0.386051:0.137332:0.386051:0.128178:0.376334:0.128178:0.004858:0.004858
The thyroid hormone thyroxine is usually given once :@0.090476:0.157056:0.485158:0.157056:0.485158:0.141273:0.090476:0.141273:0.006441:0.009223:0.009827:0.006380:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.006380:0.009223:0.009903:0.004551:0.014182:0.009903:0.009223:0.009827:0.006380:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.006380:0.003024:0.005866:0.006395:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.006395:0.010175:0.003024:0.008376:0.009827:0.009223:0.006380:0.009903:0.009223:0.009782:0.009827:0.004188
daily and should be taken on an empty stomach, ide-:@0.076189:0.171476:0.480955:0.171476:0.480955:0.155693:0.076189:0.155693:0.010357:0.010326:0.003024:0.003024:0.008104:0.005246:0.010326:0.009223:0.010357:0.005246:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005246:0.010311:0.009827:0.005246:0.005125:0.010326:0.007590:0.009827:0.009223:0.005231:0.009903:0.009223:0.005246:0.010326:0.009223:0.005246:0.009827:0.014182:0.010311:0.005125:0.008104:0.005246:0.005866:0.005125:0.009903:0.014182:0.010326:0.009782:0.009223:0.004188:0.005231:0.003024:0.010357:0.009827:0.005020
ally an hour before breakfast. The half-life of T4 is seven :@0.076189:0.185896:0.485128:0.185896:0.485128:0.170114:0.076189:0.170114:0.010326:0.003024:0.003024:0.008104:0.004596:0.010326:0.009223:0.004596:0.009223:0.009903:0.009192:0.004551:0.004581:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.004581:0.010311:0.004551:0.009827:0.010326:0.007590:0.004747:0.010326:0.005866:0.005125:0.004188:0.004596:0.006441:0.009223:0.009827:0.004581:0.009223:0.010326:0.003024:0.004747:0.005020:0.003024:0.003024:0.004747:0.009827:0.004596:0.009903:0.004747:0.004581:0.006441:0.008376:0.004596:0.003024:0.005866:0.004596:0.005866:0.009827:0.008376:0.009827:0.009223:0.004188
days and it is easily converted to the active form of T3 :@0.076189:0.200317:0.485128:0.200317:0.485128:0.184534:0.076189:0.184534:0.010357:0.010326:0.008104:0.005866:0.005231:0.010326:0.009223:0.010357:0.005231:0.003024:0.005125:0.005231:0.003024:0.005866:0.005231:0.009827:0.010326:0.005866:0.003024:0.003024:0.008104:0.005246:0.009782:0.009903:0.009223:0.008376:0.009827:0.004551:0.005125:0.009827:0.010357:0.005216:0.005125:0.009903:0.005216:0.005125:0.009223:0.009827:0.005216:0.010326:0.009782:0.005125:0.003024:0.008376:0.009827:0.005231:0.004747:0.009903:0.004551:0.014182:0.005216:0.009903:0.004747:0.005231:0.006441:0.008376:0.004188
within tissues.  Certain drugs interfere  with the gastro-:@0.076189:0.214737:0.480955:0.214737:0.480955:0.198954:0.076189:0.198954:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.007620:0.005125:0.003024:0.005866:0.005866:0.009192:0.009827:0.005866:0.004188:0.004188:0.003447:0.012292:0.009827:0.004551:0.005125:0.010326:0.003024:0.009223:0.007620:0.010357:0.004551:0.009192:0.010175:0.005866:0.007620:0.003024:0.009223:0.005125:0.009827:0.004551:0.004747:0.009827:0.004551:0.009827:0.004188:0.003417:0.012564:0.003024:0.005125:0.009223:0.007620:0.005125:0.009223:0.009827:0.007620:0.010175:0.010326:0.005866:0.005125:0.004551:0.009903:0.005020
intestinal absorption of T4, and should not be taken :@0.076189:0.229157:0.485143:0.229157:0.485143:0.213375:0.076189:0.213375:0.003024:0.009223:0.005125:0.009827:0.005866:0.005125:0.003024:0.009223:0.010326:0.003024:0.008104:0.010326:0.010311:0.005866:0.009903:0.004551:0.010311:0.005125:0.003024:0.009903:0.009223:0.008104:0.009903:0.004747:0.008104:0.006441:0.008376:0.004188:0.008104:0.010326:0.009223:0.010357:0.008104:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.008104:0.009223:0.009903:0.005125:0.008104:0.010311:0.009827:0.008104:0.005125:0.010326:0.007590:0.009827:0.009223:0.004188
simultaneously. These include bile-acid  sequestrants, :@0.076189:0.243577:0.485128:0.243577:0.485128:0.227795:0.076189:0.227795:0.005866:0.003024:0.014182:0.009192:0.003024:0.005125:0.010326:0.009223:0.009827:0.009903:0.009192:0.005866:0.003024:0.008104:0.004188:0.009767:0.006441:0.009223:0.009827:0.005866:0.009827:0.009767:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.009767:0.010311:0.003024:0.003024:0.009827:0.005020:0.010326:0.009782:0.003024:0.010357:0.004188:0.005594:0.005866:0.009827:0.010311:0.009192:0.009827:0.005866:0.005125:0.004551:0.010326:0.009223:0.005125:0.005866:0.004188:0.004188
calcium carbonate, ferrous sulphate and proton pump :@0.076189:0.257998:0.485143:0.257998:0.485143:0.242215:0.076189:0.242215:0.009782:0.010326:0.003024:0.009782:0.003024:0.009192:0.014182:0.004581:0.009782:0.010326:0.004551:0.010311:0.009903:0.009223:0.010326:0.005125:0.009827:0.004188:0.004566:0.004747:0.009827:0.004551:0.004551:0.009903:0.009192:0.005866:0.004566:0.005866:0.009192:0.003024:0.010311:0.009223:0.010326:0.005125:0.009827:0.004581:0.010326:0.009223:0.010357:0.004581:0.010311:0.004551:0.009903:0.005125:0.009903:0.009223:0.004566:0.010311:0.009192:0.014182:0.010311:0.004188
inhibitors. :@0.076189:0.272418:0.147838:0.272418:0.147838:0.256635:0.076189:0.256635:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004188:0.004188
There  are  several  formulations  of  T4  available,  and :@0.090476:0.286838:0.485098:0.286838:0.485098:0.271056:0.090476:0.271056:0.006290:0.009071:0.009676:0.004400:0.009676:0.004188:0.004294:0.010175:0.004400:0.009676:0.004188:0.004294:0.005715:0.009676:0.008225:0.009676:0.004400:0.010175:0.002873:0.004188:0.004294:0.004596:0.009752:0.004400:0.014030:0.009041:0.002873:0.010175:0.004974:0.002873:0.009752:0.009071:0.005715:0.004188:0.004294:0.009752:0.004596:0.004188:0.004294:0.006290:0.008225:0.004188:0.004294:0.010175:0.008225:0.010175:0.002873:0.002873:0.010175:0.010160:0.002873:0.009676:0.004037:0.004188:0.004294:0.010175:0.009071:0.010357:0.004188
although there might be subtle differences in bioavail-:@0.076189:0.301258:0.480955:0.301258:0.480955:0.285476:0.076189:0.285476:0.010175:0.002873:0.004974:0.009071:0.009752:0.009041:0.010024:0.009071:0.006365:0.004974:0.009071:0.009676:0.004400:0.009676:0.006365:0.014030:0.002873:0.010024:0.009071:0.004974:0.006365:0.010160:0.009676:0.006365:0.005715:0.009041:0.010160:0.004974:0.002873:0.009676:0.006365:0.010205:0.002873:0.004596:0.004596:0.009676:0.004400:0.009676:0.009071:0.009631:0.009676:0.005715:0.006365:0.002873:0.009071:0.006365:0.010160:0.002873:0.009752:0.010175:0.008225:0.010175:0.002873:0.002873:0.005020
ability between these formulations, it is currently recom-:@0.076189:0.315679:0.480955:0.315679:0.480955:0.299896:0.076189:0.299896:0.010175:0.010160:0.002873:0.002873:0.002873:0.004974:0.007953:0.005125:0.010160:0.009676:0.004974:0.012413:0.009676:0.009676:0.009071:0.005125:0.004974:0.009071:0.009676:0.005715:0.009676:0.005125:0.004596:0.009752:0.004400:0.014030:0.009041:0.002873:0.010175:0.004974:0.002873:0.009752:0.009071:0.005715:0.004037:0.005125:0.002873:0.004974:0.005125:0.002873:0.005715:0.005125:0.009631:0.009041:0.004400:0.004400:0.009676:0.009071:0.004974:0.002873:0.007953:0.005125:0.004400:0.009676:0.009631:0.009752:0.014030:0.005020
mended to stay with the same preparation, if possible.:@0.076189:0.330099:0.459562:0.330099:0.459562:0.314316:0.076189:0.314316:0.014030:0.009676:0.009071:0.010205:0.009676:0.010205:0.003235:0.004974:0.009752:0.003235:0.005715:0.004974:0.010175:0.007953:0.003235:0.012413:0.002873:0.004974:0.009071:0.003235:0.004974:0.009071:0.009676:0.003235:0.005715:0.010175:0.014030:0.009676:0.003235:0.010160:0.004400:0.009676:0.010160:0.010175:0.004400:0.010175:0.004974:0.002873:0.009752:0.009071:0.004037:0.003235:0.002873:0.004596:0.003235:0.010160:0.009752:0.005715:0.005715:0.002873:0.010160:0.002873:0.009676:0.004188
17,19:@0.459436:0.324856:0.480946:0.324856:0.480946:0.315702:0.459436:0.315702:0.004770:0.004770:0.002341:0.004770:0.004858
Clinical improvement is often fairly rapid with the intro-:@0.090476:0.344579:0.480955:0.344579:0.480955:0.328797:0.090476:0.328797:0.012292:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.003417:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.003402:0.003024:0.005866:0.003402:0.009903:0.004747:0.005125:0.009827:0.009223:0.003387:0.004747:0.010326:0.003024:0.004551:0.003024:0.008104:0.003402:0.004551:0.010326:0.010311:0.003024:0.010357:0.003402:0.012564:0.003024:0.005125:0.009223:0.003402:0.005125:0.009223:0.009827:0.003402:0.003024:0.009223:0.005125:0.004551:0.009903:0.005020
duction of thyroxine, but full recovery from severe hypo-:@0.076189:0.359000:0.480955:0.359000:0.480955:0.343217:0.076189:0.343217:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.003659:0.009903:0.004747:0.003659:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.004188:0.003659:0.010311:0.009192:0.005125:0.003674:0.004747:0.009192:0.003024:0.003024:0.003674:0.004551:0.009827:0.009782:0.009903:0.008376:0.009827:0.004551:0.008104:0.003674:0.004747:0.004551:0.009903:0.014182:0.003659:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.003674:0.009223:0.008104:0.010311:0.009903:0.005020
thyroidism may take several months.:@0.076189:0.373420:0.341286:0.373420:0.341286:0.357637:0.076189:0.357637:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.014182:0.010326:0.008104:0.004188:0.005125:0.010326:0.007590:0.009827:0.004188:0.005866:0.009827:0.008376:0.009827:0.004551:0.010326:0.003024:0.004188:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004188
Adverse effects of T4 are rare if the correct  dose is :@0.090476:0.387840:0.485128:0.387840:0.485128:0.372057:0.090476:0.372057:0.011188:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.006683:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.006683:0.009903:0.004747:0.006683:0.006441:0.008376:0.006683:0.010326:0.004551:0.009827:0.006683:0.004551:0.010326:0.004551:0.009827:0.006683:0.003024:0.004747:0.006683:0.005125:0.009223:0.009827:0.006683:0.009782:0.009903:0.004551:0.004551:0.009827:0.009782:0.005125:0.004188:0.002480:0.010357:0.009903:0.005866:0.009827:0.006683:0.003024:0.005866:0.004188
given. Overt treatment  may result in cardiovascular :@0.076189:0.402260:0.485128:0.402260:0.485128:0.386478:0.076189:0.386478:0.010175:0.003024:0.008376:0.009827:0.009223:0.004188:0.008966:0.013138:0.008376:0.009827:0.004551:0.005125:0.008966:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.004762:0.014182:0.010326:0.008104:0.008966:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.008966:0.003024:0.009223:0.008966:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188
complications, especially atrial fibrillation, as well as ac:@0.076189:0.416681:0.475951:0.416681:0.475951:0.400898:0.076189:0.400898:0.009782:0.009903:0.014182:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.004082:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004097:0.010326:0.005125:0.004551:0.003024:0.010326:0.003024:0.004082:0.003681:0.003681:0.010311:0.004551:0.003024:0.003024:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004082:0.010326:0.005866:0.004082:0.012564:0.009827:0.003024:0.003024:0.004082:0.010326:0.005866:0.004082:0.010326:0.009782
-:@0.475951:0.416681:0.480971:0.416681:0.480971:0.400898:0.475951:0.400898:0.005020
celerated bone loss and subsequent osteoporosis.:@0.076189:0.431101:0.442583:0.431101:0.442583:0.415318:0.076189:0.415318:0.009782:0.009827:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004188:0.010311:0.009903:0.009223:0.009827:0.004188:0.003024:0.009903:0.005866:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.005866:0.009192:0.010311:0.005866:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.004188:0.009903:0.005866:0.005125:0.009827:0.009903:0.010311:0.009903:0.004551:0.009903:0.005866:0.003024:0.005866:0.004188
triiodothyronine (t3) replacement :@0.076190:0.462624:0.354045:0.462624:0.354045:0.444292:0.076190:0.444292:0.007056:0.005376:0.004032:0.004032:0.010751:0.011087:0.010751:0.005040:0.010079:0.009743:0.005376:0.010751:0.010079:0.004032:0.010079:0.010751:0.004704:0.006384:0.007056:0.009407:0.006384:0.004704:0.005376:0.010751:0.011087:0.004032:0.011087:0.010751:0.010751:0.015791:0.010751:0.010079:0.005040:0.004704
The indication for T3 replacement is controversial. Nor-:@0.076190:0.479221:0.480957:0.479221:0.480957:0.463438:0.076190:0.463438:0.006441:0.009223:0.009827:0.005564:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005579:0.004747:0.009903:0.004551:0.005564:0.006441:0.008376:0.005579:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.005579:0.003024:0.005866:0.005579:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.008376:0.009827:0.004551:0.005866:0.003024:0.010326:0.003024:0.004188:0.005564:0.011188:0.009903:0.004566:0.005020
mal T3 levels  could be achieved with levothyroxine :@0.076190:0.493641:0.485145:0.493641:0.485145:0.477858:0.076190:0.477858:0.014182:0.010326:0.003024:0.008860:0.006441:0.008376:0.008860:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.004188:0.004687:0.009782:0.009903:0.009192:0.003024:0.010357:0.008860:0.010311:0.009827:0.008860:0.010326:0.009782:0.009223:0.003024:0.009827:0.008376:0.009827:0.010357:0.008860:0.012564:0.003024:0.005125:0.009223:0.008860:0.003024:0.009827:0.008376:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.004188
treatment alone in patients after total thyroidectomy. :@0.076190:0.508061:0.485160:0.508061:0.485160:0.492279:0.076190:0.492279:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.006426:0.010326:0.003024:0.009903:0.009223:0.009827:0.006441:0.003024:0.009223:0.006441:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006441:0.010326:0.004747:0.005125:0.009827:0.004551:0.006426:0.005125:0.009903:0.005125:0.010326:0.003024:0.006441:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.009827:0.009782:0.005125:0.009903:0.014182:0.008104:0.004188:0.004188
A meta-analysis evaluating 11 trials of combination T4 :@0.076190:0.522482:0.485145:0.522482:0.485145:0.506699:0.076190:0.506699:0.011188:0.006078:0.014182:0.009827:0.005125:0.010326:0.005020:0.010326:0.009223:0.010326:0.003024:0.008104:0.005866:0.003024:0.005866:0.006093:0.009827:0.008376:0.010326:0.003024:0.009192:0.010326:0.005125:0.003024:0.009223:0.010175:0.006078:0.008376:0.008376:0.006078:0.005125:0.004551:0.003024:0.010326:0.003024:0.005866:0.006078:0.009903:0.004747:0.006078:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.006078:0.006441:0.008376:0.004188
and T3 replacement therapy did not show clinical ben-:@0.076190:0.536902:0.480957:0.536902:0.480957:0.521119:0.076190:0.521119:0.010326:0.009223:0.010357:0.004430:0.006441:0.008376:0.004430:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.004430:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004430:0.010357:0.003024:0.010357:0.004430:0.009223:0.009903:0.005125:0.004415:0.005866:0.009223:0.009903:0.012564:0.004430:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004445:0.010311:0.009827:0.009223:0.005020
efit in symptoms (depression, fatigue or quality of life), or :@0.076190:0.551322:0.485145:0.551322:0.485145:0.535539:0.076190:0.535539:0.009827:0.003681:0.003681:0.005125:0.003629:0.003024:0.009223:0.003629:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.003629:0.005579:0.010357:0.009827:0.010311:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.003629:0.004747:0.010326:0.005125:0.003024:0.010175:0.009192:0.009827:0.003629:0.009903:0.004551:0.003629:0.010311:0.009192:0.010326:0.003024:0.003024:0.005125:0.008104:0.003644:0.009903:0.004747:0.003629:0.003024:0.003024:0.004747:0.009827:0.005579:0.004188:0.003629:0.009903:0.004551:0.004188
in physiological markers, such as lipid profile.:@0.076190:0.565742:0.399496:0.565742:0.399496:0.549960:0.076190:0.549960:0.003024:0.009223:0.004188:0.010311:0.009223:0.008104:0.005866:0.003024:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.004188:0.014182:0.010326:0.004551:0.007590:0.009827:0.004551:0.005866:0.004188:0.004188:0.005866:0.009192:0.009782:0.009223:0.004188:0.010326:0.005866:0.004188:0.003024:0.003024:0.010311:0.003024:0.010357:0.004188:0.010311:0.004551:0.009903:0.003681:0.003681:0.003024:0.009827:0.004188
20:@0.399493:0.560471:0.409209:0.560471:0.409209:0.551317:0.399493:0.551317:0.004858:0.004858
There are concerns that T3 treatment can cause oste-:@0.090476:0.580195:0.480940:0.580195:0.480940:0.564412:0.090476:0.564412:0.006441:0.009223:0.009827:0.004551:0.009827:0.003719:0.010326:0.004551:0.009827:0.003719:0.009782:0.009903:0.009223:0.009782:0.009827:0.004551:0.009223:0.005866:0.003719:0.005125:0.009223:0.010326:0.005125:0.003719:0.006441:0.008376:0.003719:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003704:0.009782:0.010326:0.009223:0.003719:0.009782:0.010326:0.009192:0.005866:0.009827:0.003719:0.009903:0.005866:0.005125:0.009827:0.005020
oporosis and arrhythmias. Due to evidence for the ben-:@0.076189:0.594615:0.480925:0.594615:0.480925:0.578833:0.076189:0.578833:0.009903:0.010311:0.009903:0.004551:0.009903:0.005866:0.003024:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.010326:0.004551:0.004551:0.009223:0.008104:0.005125:0.009223:0.014182:0.003024:0.010326:0.005866:0.004188:0.004188:0.011249:0.009192:0.009827:0.004203:0.005125:0.009903:0.004188:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004188:0.004747:0.009903:0.004551:0.004188:0.005125:0.009223:0.009827:0.004188:0.010311:0.009827:0.009223:0.005020
efit of levothyroxine plus triiodothyronine currently avail:@0.076189:0.609035:0.475906:0.609035:0.475906:0.593253:0.076189:0.593253:0.009827:0.003681:0.003681:0.005125:0.004082:0.009903:0.004747:0.004082:0.003024:0.009827:0.008376:0.009903:0.005125:0.009223:0.008104:0.004551:0.009888:0.007257:0.003024:0.009223:0.009827:0.004082:0.010311:0.003024:0.009192:0.005866:0.004082:0.005125:0.004551:0.003024:0.003024:0.009903:0.010357:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.009223:0.003024:0.009223:0.009827:0.004067:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.004067:0.010326:0.008376:0.010326:0.003024:0.003024
-:@0.475936:0.609035:0.480955:0.609035:0.480955:0.593253:0.475936:0.593253:0.005020
able, T4 alone should remain the treatment of choice :@0.076189:0.623456:0.485143:0.623456:0.485143:0.607673:0.076189:0.607673:0.010326:0.010311:0.003024:0.009827:0.004188:0.005957:0.006441:0.008376:0.005957:0.010326:0.003024:0.009903:0.009223:0.009827:0.005957:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005957:0.004551:0.009827:0.014182:0.010326:0.003024:0.009223:0.005942:0.005125:0.009223:0.009827:0.005942:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005942:0.009903:0.004747:0.005942:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.004188
for replacement therapy in hypothyroidism.:@0.076189:0.637876:0.392947:0.637876:0.392947:0.622093:0.076189:0.622093:0.004747:0.009903:0.004551:0.004188:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.003024:0.009223:0.004188:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188
monitoring of replacement therapy:@0.076190:0.669390:0.360764:0.669390:0.360764:0.651058:0.076190:0.651058:0.015119:0.010751:0.010079:0.004032:0.005040:0.010751:0.005376:0.004032:0.010079:0.011087:0.004704:0.010751:0.004704:0.004704:0.005376:0.010751:0.011087:0.004032:0.011087:0.010751:0.010751:0.015791:0.010751:0.010079:0.005040:0.004704:0.005040:0.010079:0.010751:0.005376:0.011087:0.011087:0.009743
In patients with primary hypothyroidism, measurement :@0.076190:0.685987:0.485145:0.685987:0.485145:0.670204:0.076190:0.670204:0.003417:0.009223:0.006214:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006229:0.012564:0.003024:0.005125:0.009223:0.006214:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.006229:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.006214:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188
of serum TsH is the cornerstone of monitoring T4 replace-:@0.076190:0.700407:0.480942:0.700407:0.480942:0.684624:0.076190:0.684624:0.009903:0.004747:0.003432:0.005866:0.009827:0.004551:0.009192:0.014182:0.003432:0.006441:0.007529:0.010326:0.003432:0.003024:0.005866:0.003447:0.005125:0.009223:0.009827:0.003432:0.009782:0.009903:0.004551:0.009223:0.009827:0.004551:0.005866:0.005125:0.009903:0.009223:0.009812:0.003432:0.009903:0.004747:0.003432:0.014182:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.003024:0.009223:0.010175:0.003417:0.006441:0.008376:0.003432:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.005020
ment. After starting levothyroxine, the level of thyroid-:@0.076190:0.714827:0.480972:0.714827:0.480972:0.699045:0.076190:0.699045:0.014182:0.009827:0.009223:0.005125:0.004188:0.006229:0.011188:0.004747:0.005125:0.009827:0.004551:0.006229:0.005866:0.005125:0.010326:0.004551:0.005125:0.003024:0.009223:0.010175:0.006229:0.003024:0.009827:0.008376:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.004188:0.006229:0.005125:0.009223:0.009827:0.006229:0.003024:0.009827:0.008376:0.009827:0.003024:0.006244:0.009903:0.004747:0.006229:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.005020
stimulating hormone commonly takes six to eight weeks :@0.076190:0.729247:0.485130:0.729247:0.485130:0.713465:0.076190:0.713465:0.005866:0.005125:0.003024:0.014182:0.009192:0.003024:0.010326:0.005125:0.003024:0.009223:0.010175:0.004067:0.009223:0.009903:0.004551:0.014167:0.009903:0.009223:0.009827:0.004052:0.009782:0.009903:0.014182:0.014182:0.009903:0.009207:0.003024:0.008104:0.004067:0.005125:0.010326:0.007590:0.009827:0.005866:0.004067:0.005866:0.003024:0.007257:0.004067:0.005125:0.009903:0.004052:0.009827:0.003024:0.010175:0.009223:0.005125:0.004052:0.012564:0.009827:0.009827:0.007590:0.005866:0.004188
to  normalise. TsH  should  be  measured  at  six weeks :@0.076190:0.743668:0.485117:0.743686:0.485117:0.727904:0.076190:0.727885:0.005125:0.009903:0.004188:0.004052:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005866:0.009827:0.004188:0.014501:0.006441:0.007529:0.010326:0.004188:0.004052:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188:0.004052:0.010311:0.009827:0.004188:0.004052:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.010357:0.004188:0.004052:0.010326:0.005125:0.004188:0.004052:0.005866:0.003024:0.007257:0.008255:0.012564:0.009827:0.009827:0.007590:0.005866:-0.124612
17 :@0.173571:0.738387:0.185716:0.738387:0.185716:0.729234:0.173571:0.729234:0.004858:0.004858:0.002429
and dose adjustments made accordingly. The patient :@0.076192:0.758106:0.485147:0.758106:0.485147:0.742324:0.076192:0.742324:0.010326:0.009223:0.010357:0.005866:0.010357:0.009903:0.005866:0.009827:0.005866:0.010326:0.010357:0.003069:0.009192:0.005866:0.005125:0.014182:0.009827:0.009223:0.005125:0.005866:0.005866:0.014182:0.010326:0.010357:0.009827:0.005866:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.003024:0.008104:0.004188:0.005851:0.006441:0.009223:0.009827:0.005851:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004188
should then be re-evaluated with TsH measurement six-:@0.076192:0.772527:0.480959:0.772527:0.480959:0.756744:0.076192:0.756744:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004339:0.005125:0.009223:0.009827:0.009223:0.004339:0.010311:0.009827:0.004339:0.004551:0.009827:0.005020:0.009827:0.008376:0.010326:0.003024:0.009192:0.010326:0.005125:0.009827:0.010357:0.004339:0.012564:0.003024:0.005125:0.009223:0.004339:0.006441:0.007529:0.010326:0.004339:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.014182:0.009827:0.009223:0.005125:0.004324:0.005866:0.003024:0.007257:0.005020
weekly. T4 dose should be adjusted to maintain the lev-:@0.076192:0.786947:0.480959:0.786947:0.480959:0.771164:0.076192:0.771164:0.012564:0.009827:0.009827:0.007590:0.003024:0.008104:0.004188:0.004127:0.006441:0.008376:0.004127:0.010357:0.009903:0.005866:0.009827:0.004127:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004127:0.010311:0.009827:0.004127:0.010326:0.010357:0.003069:0.009192:0.005866:0.005125:0.009827:0.010357:0.004127:0.005125:0.009903:0.004127:0.014182:0.010326:0.003024:0.009223:0.005125:0.010326:0.003024:0.009223:0.004127:0.005125:0.009223:0.009827:0.004127:0.003024:0.009827:0.008376:0.005020
el of thyroid-stimulating hormone within the reference :@0.076192:0.801367:0.485162:0.801367:0.485162:0.785585:0.076192:0.785585:0.009827:0.003024:0.006395:0.009903:0.004747:0.006395:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.005020:0.005866:0.005125:0.003024:0.014182:0.009192:0.003024:0.010326:0.005125:0.003024:0.009223:0.010175:0.006395:0.009223:0.009903:0.004551:0.014182:0.009903:0.009223:0.009827:0.006380:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.006395:0.005125:0.009223:0.009827:0.006395:0.004551:0.009827:0.004747:0.009827:0.004551:0.009827:0.009223:0.009782:0.009827:0.004188
range.:@0.076192:0.815788:0.124482:0.815788:0.124482:0.800005:0.076192:0.800005:0.004551:0.010326:0.009223:0.010175:0.009827:0.004188
9:@0.124471:0.810512:0.129329:0.810512:0.129329:0.801358:0.124471:0.801358:0.004858
 Thereafter, annual TSH measurement is sufficient :@0.129331:0.815811:0.485112:0.815811:0.485112:0.800028:0.129331:0.800028:0.003704:0.006441:0.009223:0.009827:0.004551:0.009827:0.010326:0.004732:0.005125:0.009827:0.004551:0.004188:0.003689:0.010326:0.009223:0.009223:0.009192:0.010326:0.003024:0.003704:0.006441:0.007529:0.010326:0.003704:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.014182:0.009827:0.009223:0.005125:0.003689:0.003024:0.005866:0.003704:0.005866:0.009192:0.004747:0.003681:0.003681:0.009782:0.003024:0.009827:0.009223:0.005125:0.004188
for someone receiving a stable dose of levothyroxine. :@0.076187:0.830231:0.472397:0.830231:0.472397:0.814448:0.076187:0.814448:0.004747:0.009903:0.004551:0.004188:0.005866:0.009903:0.014182:0.009827:0.009903:0.009223:0.009827:0.004188:0.004551:0.009827:0.009782:0.009827:0.003024:0.008376:0.003024:0.009223:0.010175:0.004188:0.010326:0.004188:0.005866:0.005125:0.010326:0.010311:0.003024:0.009827:0.004188:0.010357:0.009903:0.005866:0.009827:0.004188:0.009903:0.004747:0.004188:0.003024:0.009827:0.008376:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.004188:0.004188
In  patients  with  pituitary  insufficiency,  fT:@0.533327:0.084926:0.840757:0.084926:0.840757:0.069144:0.533327:0.069144:0.003417:0.009223:0.004188:0.004354:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.004354:0.012564:0.003024:0.005125:0.009223:0.004188:0.004354:0.010311:0.003024:0.005125:0.009192:0.003024:0.005125:0.010326:0.004551:0.008104:0.004188:0.004354:0.003024:0.009223:0.005866:0.009192:0.004747:0.003681:0.003681:0.009782:0.003024:0.009827:0.009223:0.009782:0.008104:0.004188:0.004188:0.004354:0.004747:0.006441
4 :@0.840789:0.084597:0.848076:0.084597:0.848076:0.075443:0.840789:0.075443:0.004858:0.002429
levels are :@0.850606:0.084931:0.928001:0.084931:0.928001:0.069149:0.850606:0.069149:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.008557:0.010326:0.004551:0.009827:0.004188
measured to determine whether patients remain euthy-:@0.519046:0.099305:0.923798:0.099305:0.923798:0.083523:0.519046:0.083523:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.010357:0.003810:0.005125:0.009903:0.003810:0.010357:0.009827:0.005125:0.009827:0.004551:0.014182:0.003024:0.009223:0.009827:0.003810:0.012564:0.009223:0.009827:0.005125:0.009223:0.009827:0.004551:0.003810:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003810:0.004551:0.009827:0.014182:0.010326:0.003024:0.009223:0.003810:0.009827:0.009192:0.005125:0.009223:0.008104:0.005020
roid. The goal is to maintain fT4 levels in the mid to upper :@0.519046:0.113679:0.928001:0.113679:0.928001:0.097897:0.519046:0.097897:0.004551:0.009903:0.003024:0.010357:0.004188:0.003553:0.006441:0.009223:0.009812:0.003568:0.010175:0.009903:0.010326:0.003024:0.003568:0.003024:0.005866:0.003568:0.005125:0.009903:0.003553:0.014182:0.010326:0.003024:0.009223:0.005125:0.010326:0.003024:0.009223:0.003568:0.004747:0.006441:0.008376:0.003568:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.003568:0.003024:0.009223:0.003568:0.005125:0.009223:0.009827:0.003553:0.014182:0.003024:0.010357:0.003568:0.005125:0.009903:0.003553:0.009192:0.010311:0.010311:0.009827:0.004551:0.004188
range of normal to ensure adequate replacement.:@0.519046:0.128054:0.893136:0.128054:0.893136:0.112271:0.519046:0.112271:0.004551:0.010326:0.009223:0.010175:0.009827:0.004188:0.009903:0.004747:0.004188:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.004188:0.005125:0.009903:0.004188:0.009827:0.009223:0.005866:0.009192:0.004551:0.009827:0.004188:0.010326:0.010357:0.009827:0.010311:0.009192:0.010326:0.005125:0.009827:0.004188:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188
subCliniCAl HyPOtHyrOiDism:@0.519047:0.161158:0.796599:0.161158:0.796599:0.140993:0.519047:0.140993:0.009609:0.011826:0.010718:0.014413:0.008131:0.005174:0.013674:0.005174:0.014413:0.013674:0.008131:0.005174:0.012566:0.011457:0.010348:0.015522:0.007761:0.012566:0.011457:0.010718:0.015522:0.005174:0.012935:0.005174:0.009609:0.016631
Subclinical hypothyroidism is defined as a biochemical :@0.519047:0.177306:0.927987:0.177306:0.927987:0.161523:0.519047:0.161523:0.007529:0.009192:0.010311:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.005156:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.005140:0.003024:0.005866:0.005140:0.010357:0.009827:0.003681:0.003681:0.009223:0.009827:0.010357:0.005125:0.010326:0.005866:0.005140:0.010326:0.005140:0.010311:0.003024:0.009903:0.009782:0.009223:0.009827:0.014182:0.003024:0.009782:0.010326:0.003024:0.004188
abnormality, characterised by a mildly  elevated TsH :@0.519047:0.191680:0.927987:0.191680:0.927987:0.175897:0.519047:0.175897:0.010326:0.010311:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.008074:0.009782:0.009223:0.010326:0.004551:0.010326:0.009782:0.005125:0.009827:0.004551:0.003024:0.005866:0.009827:0.010357:0.008074:0.010311:0.008104:0.008074:0.010326:0.008074:0.014182:0.003024:0.003024:0.010357:0.003024:0.008104:0.004188:0.003901:0.009827:0.003024:0.009827:0.008376:0.010326:0.005125:0.009827:0.010357:0.008074:0.006441:0.007529:0.010326:0.004188
level, with normal thyroxine and triiodothyronine levels :@0.519047:0.206054:0.927972:0.206054:0.927972:0.190272:0.519047:0.190272:0.003024:0.009827:0.008376:0.009827:0.003024:0.004188:0.005866:0.012564:0.003024:0.005125:0.009223:0.005866:0.009223:0.009903:0.004551:0.014167:0.010326:0.003024:0.005866:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.005851:0.010326:0.009223:0.010357:0.005866:0.005125:0.004551:0.003024:0.003024:0.009903:0.010357:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.009223:0.003024:0.009223:0.009827:0.005851:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.004188
and no or very mild, non-specific clinical symptoms. :@0.519047:0.220428:0.899926:0.220428:0.899926:0.204646:0.519047:0.204646:0.010326:0.009223:0.010357:0.004188:0.009223:0.009903:0.004188:0.009903:0.004551:0.004188:0.008376:0.009827:0.004551:0.008104:0.004188:0.014182:0.003024:0.003024:0.010357:0.004188:0.004188:0.009223:0.009903:0.009223:0.005020:0.005866:0.010311:0.009827:0.009782:0.003024:0.003681:0.003681:0.009782:0.004188:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.004188
The prevalence of subclinical hypothyroidism ranges :@0.533335:0.234802:0.928002:0.234802:0.928002:0.219020:0.533335:0.219020:0.006441:0.009223:0.009827:0.005549:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.005564:0.009903:0.004747:0.005564:0.005866:0.009192:0.010311:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.005579:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.005564:0.004551:0.010326:0.009223:0.010175:0.009827:0.005866:0.004188
from 1-10% of the adult population, and is more preva-:@0.519047:0.249176:0.923799:0.249176:0.923799:0.233394:0.519047:0.233394:0.004747:0.004551:0.009903:0.014182:0.004717:0.008376:0.005020:0.008376:0.008376:0.011717:0.004717:0.009903:0.004747:0.004717:0.005125:0.009223:0.009827:0.004717:0.010326:0.010357:0.009192:0.003024:0.005125:0.004717:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004717:0.010326:0.009223:0.010357:0.004717:0.003024:0.005866:0.004717:0.014182:0.009903:0.004551:0.009827:0.004717:0.010311:0.004551:0.009827:0.008376:0.010326:0.005020
lent in the elderly, in females and in Caucasians.:@0.519047:0.263551:0.871684:0.263551:0.871684:0.247768:0.519047:0.247768:0.003024:0.009827:0.009223:0.005125:0.004188:0.003024:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.009827:0.003024:0.010357:0.009827:0.004551:0.003024:0.008104:0.004188:0.004188:0.003024:0.009223:0.004188:0.004747:0.009827:0.014182:0.010326:0.003024:0.009827:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.003024:0.009223:0.004188:0.012292:0.010326:0.009192:0.009782:0.010326:0.005866:0.003024:0.010326:0.009223:0.005866:0.004188
The prevalence is also higher in populations with high :@0.533335:0.277925:0.928002:0.277925:0.928002:0.262142:0.533335:0.262142:0.006441:0.009223:0.009827:0.004475:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.004475:0.003024:0.005866:0.004490:0.010326:0.003024:0.005866:0.009903:0.004490:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.004475:0.003024:0.009223:0.004475:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004490:0.012564:0.003024:0.005125:0.009223:0.004475:0.009223:0.003024:0.010175:0.009223:0.004188
iodine intake.:@0.519047:0.292299:0.617895:0.292299:0.617895:0.276516:0.519047:0.276516:0.003024:0.009903:0.010357:0.003024:0.009223:0.009827:0.004188:0.003024:0.009223:0.005125:0.010326:0.007590:0.009827:0.004188
21:@0.617889:0.286967:0.627606:0.286967:0.627606:0.277813:0.617889:0.277813:0.004858:0.004858
subclinical hypothyroidism has a high rate of progres-:@0.533333:0.306635:0.923812:0.306635:0.923812:0.290853:0.533333:0.290853:0.007529:0.009192:0.010311:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004173:0.009223:0.010326:0.005866:0.004188:0.010326:0.004188:0.009223:0.003024:0.010175:0.009223:0.004173:0.004551:0.010326:0.005125:0.009827:0.004173:0.009903:0.004747:0.004173:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005881:0.005020
sion to overt hypothyroidism, 2.6% per year if TpO anti-:@0.519045:0.321009:0.923797:0.321009:0.923797:0.305227:0.519045:0.305227:0.005866:0.003024:0.009903:0.009223:0.005518:0.005125:0.009903:0.005518:0.009903:0.008376:0.009827:0.004551:0.005125:0.005518:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.005518:0.008376:0.004188:0.008376:0.011717:0.005518:0.010311:0.009827:0.004551:0.005518:0.008104:0.009827:0.010326:0.004551:0.005518:0.003024:0.004747:0.005518:0.006441:0.008950:0.013138:0.005518:0.010326:0.009223:0.005125:0.003024:0.005020
bodies are absent, and 4.3% if they are present. The risk :@0.519045:0.335383:0.927985:0.335383:0.927985:0.319601:0.519045:0.319601:0.010311:0.009903:0.010357:0.003024:0.009827:0.005866:0.004324:0.010326:0.004551:0.009827:0.004309:0.010326:0.010311:0.005866:0.009827:0.009223:0.005125:0.004188:0.004309:0.010326:0.009223:0.010357:0.004309:0.008376:0.004188:0.008376:0.011717:0.004324:0.003024:0.004747:0.004324:0.005125:0.009223:0.009827:0.008104:0.004309:0.010326:0.004551:0.009827:0.004309:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.004188:0.004309:0.006441:0.009223:0.009827:0.004309:0.004551:0.003024:0.005866:0.007590:0.004188
of progression is also higher in women and those with :@0.519045:0.349757:0.927970:0.349757:0.927970:0.333975:0.519045:0.333975:0.009903:0.004747:0.006123:0.010311:0.004551:0.009903:0.010160:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.006123:0.003024:0.005866:0.006138:0.010326:0.003024:0.005866:0.009903:0.006138:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.006123:0.003024:0.009223:0.006123:0.012564:0.009903:0.014182:0.009827:0.009223:0.006123:0.010326:0.009223:0.010357:0.006123:0.005125:0.009223:0.009903:0.005866:0.009827:0.006123:0.012564:0.003024:0.005125:0.009223:0.004188
high  baseline levels of  TsH.  some  patients do  experi-:@0.519045:0.364132:0.923797:0.364132:0.923797:0.348349:0.519045:0.348349:0.009223:0.003024:0.010175:0.009223:0.004188:0.003084:0.010311:0.010326:0.005866:0.009827:0.003024:0.003024:0.009223:0.009827:0.007287:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.007287:0.009903:0.004747:0.004188:0.003084:0.006441:0.007529:0.010326:0.004188:0.004188:0.003115:0.007529:0.009903:0.014182:0.009827:0.004188:0.003084:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.007287:0.010357:0.009903:0.004188:0.003084:0.009827:0.007257:0.010311:0.009827:0.004551:0.003024:0.005020
ence  normalisation  of  thyroid  function  and  many  pa-:@0.519045:0.378506:0.923782:0.378506:0.923782:0.362723:0.519045:0.362723:0.009827:0.009223:0.009782:0.009827:0.004188:0.002359:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.002359:0.009903:0.004747:0.004188:0.002359:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.004188:0.002359:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.002359:0.010326:0.009223:0.010357:0.004188:0.002359:0.014182:0.010326:0.009223:0.008104:0.004188:0.002359:0.010311:0.010326:0.005020
tients have stable subclinical hypothyroidism without :@0.519045:0.392880:0.928015:0.392880:0.928015:0.377097:0.519045:0.377097:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.008542:0.009223:0.010326:0.008376:0.009827:0.008542:0.005866:0.005125:0.010326:0.010311:0.003024:0.009827:0.008542:0.005866:0.009192:0.010311:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010341:0.003024:0.008542:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.008542:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.004188
deterioration in thyroid function.:@0.519045:0.407254:0.753315:0.407254:0.753315:0.391471:0.519045:0.391471:0.010357:0.009827:0.005125:0.009827:0.004551:0.003024:0.009903:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003024:0.009223:0.004188:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.004188:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
22:@0.753282:0.401926:0.762998:0.401926:0.762998:0.392772:0.753282:0.392772:0.004858:0.004858
Considerable  debate  exists  about  whether  to  treat :@0.533333:0.421594:0.927970:0.421594:0.927970:0.405812:0.533333:0.405812:0.012141:0.009752:0.009071:0.005715:0.002873:0.010205:0.009676:0.004400:0.010175:0.010160:0.002873:0.009676:0.004188:0.004203:0.010205:0.009676:0.010160:0.010175:0.004974:0.009676:0.004188:0.004203:0.009676:0.007106:0.002873:0.005715:0.004974:0.005715:0.004188:0.004203:0.010175:0.010160:0.009752:0.009041:0.004974:0.004188:0.004203:0.012413:0.009071:0.009676:0.004974:0.009071:0.009676:0.004400:0.004188:0.004203:0.004974:0.009752:0.004188:0.004203:0.004974:0.004400:0.009676:0.010175:0.005125:0.004188
patients with subclinical hypothyroidism and no definite :@0.519045:0.435968:0.928015:0.435968:0.928015:0.420186:0.519045:0.420186:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.005337:0.012413:0.002873:0.004974:0.009071:0.005337:0.005715:0.009041:0.010160:0.009631:0.002873:0.002873:0.009071:0.002873:0.009631:0.010175:0.002873:0.005337:0.009071:0.007953:0.010160:0.009752:0.004974:0.009071:0.007953:0.004400:0.009752:0.002873:0.010205:0.002873:0.005715:0.014030:0.005337:0.010175:0.009071:0.010205:0.005337:0.009071:0.009752:0.005337:0.010205:0.009676:0.003606:0.003606:0.009071:0.002873:0.004974:0.009827:0.004188
indications for treatment have been established. It is not :@0.519045:0.450343:0.928000:0.450343:0.928000:0.434560:0.519045:0.434560:0.002873:0.009071:0.010205:0.002873:0.009631:0.010175:0.004974:0.002873:0.009752:0.009071:0.005715:0.004400:0.004596:0.009752:0.004400:0.004400:0.004974:0.004400:0.009676:0.010175:0.004974:0.014030:0.009676:0.009071:0.004974:0.004400:0.009071:0.010175:0.008225:0.009676:0.004400:0.010160:0.009676:0.009676:0.009071:0.004400:0.009676:0.005715:0.004974:0.010175:0.010160:0.002873:0.002873:0.005715:0.009071:0.009676:0.010205:0.004037:0.004400:0.003266:0.004974:0.004400:0.002873:0.005715:0.004400:0.009071:0.009752:0.005125:0.004188
clear if the benefits of treating subclinical hypothyroidism :@0.519045:0.464717:0.927955:0.464717:0.927955:0.448934:0.519045:0.448934:0.009631:0.002873:0.009676:0.010175:0.004400:0.003704:0.002873:0.004596:0.003704:0.004974:0.009071:0.009676:0.003704:0.010160:0.009676:0.009071:0.009676:0.003606:0.003606:0.004974:0.005715:0.003704:0.009752:0.004596:0.003704:0.004974:0.004400:0.009676:0.010175:0.004974:0.002873:0.009071:0.010024:0.003704:0.005715:0.009041:0.010160:0.009631:0.002873:0.002873:0.009071:0.002873:0.009631:0.010175:0.002873:0.003704:0.009071:0.007953:0.010160:0.009752:0.004974:0.009071:0.007953:0.004400:0.009752:0.002873:0.010205:0.002873:0.005715:0.014182:0.004188
outweigh the risks and potential complications.:@0.519045:0.479091:0.856593:0.479091:0.856593:0.463308:0.519045:0.463308:0.009752:0.009041:0.004974:0.012413:0.009676:0.002873:0.010024:0.009071:0.004037:0.004974:0.009071:0.009676:0.004037:0.004400:0.002873:0.005715:0.007439:0.005715:0.004037:0.010175:0.009071:0.010205:0.004037:0.010160:0.009752:0.004974:0.009676:0.009071:0.004974:0.002873:0.010175:0.002873:0.004037:0.009631:0.009752:0.014030:0.010160:0.002873:0.002873:0.009631:0.010175:0.004974:0.002873:0.009752:0.009071:0.005715:0.004188
21:@0.856423:0.473775:0.866052:0.473775:0.866052:0.464621:0.856423:0.464621:0.004770:0.004858
Current consensus guidelines recommend treatment :@0.533333:0.493444:0.928000:0.493444:0.928000:0.477661:0.533333:0.477661:0.012292:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.005564:0.009782:0.009903:0.009223:0.005866:0.009827:0.009223:0.005866:0.009192:0.005866:0.005579:0.010175:0.009192:0.003024:0.010357:0.009827:0.003024:0.003024:0.009223:0.009827:0.005866:0.005579:0.004551:0.009827:0.009782:0.009903:0.014182:0.014182:0.009827:0.009223:0.010357:0.005564:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188
for subclinical hypothyroidism in patients with::@0.519045:0.507818:0.851861:0.507818:0.851861:0.492035:0.519045:0.492035:0.004747:0.009903:0.004551:0.004188:0.005866:0.009192:0.010311:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.003024:0.009223:0.004188:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188
21,23:@0.851858:0.502515:0.873719:0.502515:0.873719:0.493361:0.851858:0.493361:0.004858:0.004858:0.002429:0.004858:0.004858
•  Positive test for antibodies against thyroperoxidase:@0.519047:0.522184:0.908589:0.522184:0.908589:0.506401:0.519047:0.506401:0.009162:0.004188:0.006804:0.008950:0.009903:0.005866:0.003024:0.005125:0.003024:0.008376:0.009827:0.004188:0.005125:0.009827:0.005866:0.005125:0.004188:0.004747:0.009903:0.004551:0.004188:0.010326:0.009223:0.005125:0.003024:0.010311:0.009903:0.010357:0.003024:0.009827:0.005866:0.004188:0.010326:0.010175:0.010326:0.003024:0.009223:0.005866:0.005125:0.004188:0.005125:0.009223:0.008104:0.004551:0.009903:0.010311:0.009827:0.004551:0.009903:0.007257:0.003024:0.010357:0.010326:0.005866:0.009827
•  Serum TSH levels greater than 10 mU/L:@0.519047:0.536558:0.816560:0.536558:0.816560:0.520775:0.519047:0.520775:0.009162:0.004188:0.006804:0.007529:0.009827:0.004551:0.009192:0.014182:0.004188:0.006441:0.007529:0.010326:0.004188:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.004188:0.010175:0.004551:0.009827:0.010326:0.005125:0.009827:0.004551:0.004188:0.005125:0.009223:0.010326:0.009223:0.004188:0.008376:0.008376:0.004188:0.014182:0.009903:0.006607:0.006985
•  Severe symptoms :@0.519047:0.550932:0.671054:0.550932:0.671054:0.535149:0.519047:0.535149:0.009162:0.004188:0.006804:0.007529:0.009827:0.008376:0.009827:0.004551:0.009827:0.004188:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188
•  High total or LDL cholesterol levels:@0.519047:0.565306:0.786064:0.565306:0.786064:0.549523:0.519047:0.549523:0.009162:0.004188:0.006804:0.010326:0.003024:0.010175:0.009223:0.004188:0.005125:0.009903:0.005125:0.010326:0.003024:0.004188:0.009903:0.004551:0.004188:0.006985:0.011249:0.006985:0.004188:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866
•  Goitre:@0.519047:0.579680:0.584815:0.579680:0.584815:0.563897:0.519047:0.563897:0.009162:0.004188:0.006804:0.013184:0.009903:0.003024:0.005125:0.004551:0.009827
•  Pregnancy:@0.519047:0.594054:0.619362:0.594054:0.619362:0.578271:0.519047:0.578271:0.009162:0.004188:0.006804:0.008950:0.004551:0.009827:0.010175:0.009223:0.010326:0.009223:0.009782:0.008104
•  Female infertility with ovulatory dysfunction:@0.519047:0.608428:0.852256:0.608428:0.852256:0.592646:0.519047:0.592646:0.009162:0.004188:0.006804:0.007333:0.009827:0.014182:0.010326:0.003024:0.009827:0.004188:0.003024:0.009223:0.004747:0.009827:0.004551:0.005125:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.009903:0.008376:0.009192:0.003024:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223
 :@0.852240:0.608428:0.856474:0.608428:0.856474:0.591930:0.852240:0.591930:0.004233
sCreeninG fOr HyPOtHyrOiDism:@0.519047:0.641520:0.823948:0.641520:0.823948:0.621355:0.519047:0.621355:0.009609:0.014413:0.010718:0.009609:0.009609:0.013674:0.005174:0.013674:0.015522:0.005174:0.008870:0.015522:0.010718:0.005174:0.012566:0.011457:0.010348:0.015522:0.007761:0.012566:0.011457:0.010718:0.015522:0.005174:0.012935:0.005174:0.009609:0.016631
There  is  currently  no  proven  benefit  for  screening  all :@0.519047:0.657668:0.927987:0.657668:0.927987:0.641886:0.519047:0.641886:0.006441:0.009223:0.009827:0.004551:0.009827:0.004188:0.003629:0.003024:0.005866:0.004188:0.003644:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.004188:0.003629:0.009223:0.009903:0.004188:0.003629:0.010311:0.004551:0.009903:0.008376:0.009827:0.009223:0.004188:0.003629:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.004188:0.003629:0.004747:0.009903:0.004551:0.004188:0.003629:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.003024:0.009223:0.010175:0.004188:0.003629:0.010326:0.003024:0.003024:0.004188
people  for  hypothyroidism.  Currently  the  American :@0.519047:0.672042:0.928002:0.672042:0.928002:0.656260:0.519047:0.656260:0.010311:0.009827:0.009903:0.010311:0.003024:0.009827:0.004188:0.006834:0.004747:0.009903:0.004551:0.004188:0.006834:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.004188:0.006834:0.012292:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.004188:0.006834:0.005125:0.009223:0.009827:0.004188:0.006834:0.011188:0.014182:0.009827:0.004551:0.003024:0.009782:0.010326:0.009223:0.004188
Thyroid Association recommends measurement of thy-:@0.519047:0.686416:0.923799:0.686416:0.923799:0.670634:0.519047:0.670634:0.006441:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.005594:0.011188:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005594:0.004551:0.009827:0.009782:0.009903:0.014182:0.014182:0.009812:0.009223:0.010357:0.005866:0.005609:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.014182:0.009827:0.009223:0.005125:0.005594:0.009903:0.004747:0.005594:0.005125:0.009223:0.008104:0.005020
roid functions in all adults older than 35 years, and then :@0.519047:0.700790:0.928002:0.700790:0.928002:0.685008:0.519047:0.685008:0.004551:0.009903:0.003024:0.010357:0.004385:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.005866:0.004385:0.003024:0.009223:0.004385:0.010326:0.003024:0.003024:0.004400:0.010326:0.010357:0.009192:0.003024:0.005125:0.005866:0.004385:0.009903:0.003024:0.010357:0.009827:0.004551:0.004385:0.005125:0.009223:0.010326:0.009223:0.004385:0.008376:0.008376:0.004385:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.004385:0.010326:0.009223:0.010357:0.004385:0.005125:0.009223:0.009827:0.009223:0.004188
every five years thereafter,:@0.519047:0.715165:0.716351:0.715165:0.716351:0.699382:0.519047:0.699382:0.009827:0.008376:0.009827:0.004551:0.008104:0.005020:0.003681:0.003681:0.008376:0.009827:0.005020:0.008104:0.009827:0.010326:0.004551:0.005866:0.005020:0.005125:0.009223:0.009827:0.004551:0.009827:0.010326:0.004747:0.005125:0.009827:0.004551:0.004188
24:@0.716319:0.709849:0.726036:0.709849:0.726036:0.700695:0.716319:0.700695:0.004858:0.004858
 noting that more frequent :@0.726039:0.715148:0.927999:0.715148:0.927999:0.699365:0.726039:0.699365:0.005020:0.009223:0.009903:0.005125:0.003024:0.009223:0.010175:0.005004:0.005125:0.009223:0.010326:0.005125:0.005004:0.014182:0.009903:0.004551:0.009827:0.005004:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.004188
screening  may be  appropriate  in  high-risk  or  sympto-:@0.519044:0.729522:0.923781:0.729522:0.923781:0.713739:0.519044:0.713739:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.003024:0.009223:0.010175:0.004188:0.002812:0.014182:0.010326:0.008104:0.007015:0.010311:0.009827:0.004188:0.002812:0.010326:0.010311:0.010311:0.004551:0.009903:0.010311:0.004551:0.003024:0.010326:0.005125:0.009827:0.004188:0.002812:0.003024:0.009223:0.004188:0.002812:0.009223:0.003024:0.010175:0.009223:0.005020:0.004551:0.003024:0.005866:0.007590:0.004188:0.002812:0.009903:0.004551:0.004188:0.002812:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.005020
matic individuals.:@0.519044:0.743896:0.645651:0.743896:0.645651:0.728113:0.519044:0.728113:0.014182:0.010326:0.005125:0.003024:0.009782:0.004188:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010357:0.009192:0.010326:0.003024:0.005866:0.004188
The  United  Kingdom  guidelines do  not  recommend :@0.533332:0.758270:0.927984:0.758270:0.927984:0.742488:0.533332:0.742488:0.006441:0.009223:0.009827:0.004188:0.002782:0.009903:0.009223:0.003024:0.005125:0.009827:0.010357:0.004188:0.002782:0.008935:0.003024:0.009223:0.010175:0.010357:0.009903:0.014182:0.004188:0.002782:0.010175:0.009192:0.003024:0.010357:0.009827:0.003024:0.003024:0.009223:0.009827:0.005866:0.006985:0.010357:0.009903:0.004188:0.002782:0.009223:0.009903:0.005125:0.004188:0.002782:0.004551:0.009827:0.009782:0.009903:0.014182:0.014182:0.009827:0.009223:0.010357:0.004188
screening in the healthy asymptomatic population, but :@0.519044:0.772644:0.927999:0.772644:0.927999:0.756862:0.519044:0.756862:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.003024:0.009223:0.010175:0.004430:0.003024:0.009223:0.004430:0.005125:0.009223:0.009827:0.004430:0.009223:0.009827:0.010326:0.003024:0.005125:0.009223:0.008104:0.004430:0.010326:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.010326:0.005125:0.003024:0.009782:0.004430:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004430:0.010311:0.009192:0.005125:0.004188
testing women at menopause or patients with non-spe-:@0.519044:0.787018:0.923826:0.787018:0.923826:0.771236:0.519044:0.771236:0.005125:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175:0.004143:0.012564:0.009903:0.014182:0.009827:0.009223:0.004143:0.010326:0.005125:0.004143:0.014182:0.009827:0.009223:0.009903:0.010311:0.010326:0.009192:0.005866:0.009827:0.004143:0.009903:0.004551:0.004143:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004143:0.012564:0.003024:0.005125:0.009223:0.004143:0.009223:0.009903:0.009223:0.005020:0.005866:0.010311:0.009827:0.005020
cific  symptoms  is  justified.  It  also  recommends  annual :@0.519044:0.801392:0.927999:0.801392:0.927999:0.785610:0.519044:0.785610:0.009782:0.003024:0.003681:0.003681:0.009782:0.004188:0.002631:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.002631:0.003024:0.005866:0.004188:0.002631:0.003069:0.009192:0.005866:0.005125:0.003024:0.003681:0.003681:0.009827:0.010357:0.004188:0.004188:0.002631:0.003417:0.005125:0.004188:0.002616:0.010326:0.003024:0.005866:0.009903:0.004188:0.002631:0.004551:0.009827:0.009782:0.009903:0.014182:0.014182:0.009827:0.009223:0.010357:0.005866:0.004188:0.002616:0.010326:0.009223:0.009223:0.009192:0.010326:0.003024:0.004188
screening for people at high risk of developing hypo-:@0.519044:0.815766:0.923796:0.815766:0.923796:0.799984:0.519044:0.799984:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.003024:0.009223:0.010175:0.006426:0.004747:0.009903:0.004551:0.006426:0.010311:0.009827:0.009903:0.010311:0.003024:0.009827:0.006441:0.010326:0.005125:0.006441:0.009223:0.003024:0.010175:0.009223:0.006426:0.004551:0.003024:0.005866:0.007590:0.006441:0.009903:0.004747:0.006426:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.003024:0.009223:0.010175:0.006441:0.009223:0.008104:0.010311:0.009903:0.005020
thyroidism (see Table 4).:@0.519044:0.830268:0.694138:0.830268:0.694138:0.814485:0.519044:0.814485:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.005579:0.005866:0.009827:0.009827:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.004188:0.008376:0.005579:0.004188
25:@0.694142:0.824937:0.703858:0.824937:0.703858:0.815783:0.694142:0.815783:0.004858:0.004858
table 3. thyroxine replacement starting dose:@0.077030:0.868513:0.404206:0.868513:0.404206:0.852014:0.077030:0.852014:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.006350:0.009071:0.008769:0.004838:0.009676:0.008467:0.003629:0.009071:0.009676:0.004233:0.004838:0.009676:0.009979:0.003629:0.009979:0.009676:0.009676:0.014212:0.009676:0.009071:0.004536:0.004233:0.006652:0.004536:0.009979:0.004838:0.004536:0.003629:0.009071:0.009979:0.004233:0.009979:0.009676:0.006652:0.009676
18:@0.404194:0.863214:0.414015:0.863214:0.414015:0.853645:0.404194:0.853645:0.004911:0.004911
• :@0.112308:0.886468:0.121850:0.886468:0.121850:0.873897:0.112308:0.873897:0.006182:0.003360
Young patient:@0.142546:0.887361:0.235518:0.887361:0.235518:0.873332:0.142546:0.873332:0.007956:0.008803:0.008171:0.008198:0.009045:0.003723:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556
• :@0.112308:0.899297:0.121850:0.899297:0.121850:0.886725:0.112308:0.886725:0.006182:0.003360
No CV risk factors:@0.142546:0.900190:0.256228:0.900190:0.256228:0.886161:0.142546:0.886161:0.009945:0.008803:0.003723:0.010926:0.009434:0.003723:0.004045:0.002688:0.005214:0.006746:0.003723:0.004220:0.009179:0.008695:0.004556:0.008803:0.004045:0.005214
Start T4 at 75 μg/ day.:@0.376885:0.887361:0.518748:0.887361:0.518748:0.873332:0.376885:0.873332:0.006693:0.004556:0.009179:0.004045:0.004556:0.003723:0.005725:0.007445:0.003723:0.009179:0.004556:0.003723:0.007445:0.007445:0.003723:0.008198:0.009045:0.005873:0.003723:0.009206:0.009179:0.007203:0.003723
 :@0.518735:0.887361:0.522457:0.887361:0.522457:0.873332:0.518735:0.873332:0.003723
Increase slowly if indicated by continued elevation of TsH level.:@0.376885:0.900190:0.787329:0.900190:0.787329:0.886161:0.376885:0.886161:0.003037:0.008198:0.008695:0.004045:0.008735:0.009179:0.005214:0.008735:0.003723:0.005214:0.002688:0.008803:0.011168:0.002688:0.007203:0.003723:0.002688:0.004220:0.003723:0.002688:0.008198:0.009206:0.002688:0.008695:0.009179:0.004556:0.008735:0.009206:0.003723:0.009165:0.007203:0.003723:0.008695:0.008803:0.008198:0.004556:0.002688:0.008198:0.008171:0.008735:0.009206:0.003723:0.008735:0.002688:0.008735:0.007445:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.005725:0.006693:0.009179:0.003723:0.002688:0.008735:0.007445:0.008735:0.002688:0.003723
• :@0.112308:0.914691:0.121850:0.914691:0.121850:0.902119:0.112308:0.902119:0.006182:0.003360
Older patients(>60 years) :@0.142546:0.915584:0.309689:0.915584:0.309689:0.901555:0.142546:0.901555:0.011679:0.002688:0.009206:0.008735:0.004045:0.003723:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.005214:0.004959:0.008144:0.007445:0.007445:0.003723:0.007203:0.008735:0.009179:0.004045:0.005214:0.004959:0.003723
• :@0.112308:0.927519:0.121850:0.927519:0.121850:0.914947:0.112308:0.914947:0.006182:0.003360
patient at risk for CV disease:@0.142546:0.928412:0.325856:0.928412:0.325856:0.914383:0.142546:0.914383:0.007956:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.003723:0.009179:0.004556:0.003723:0.004045:0.002688:0.005214:0.006746:0.003723:0.004220:0.008803:0.004045:0.003723:0.010926:0.009434:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735
• :@0.112308:0.940347:0.121850:0.940347:0.121850:0.927776:0.112308:0.927776:0.006182:0.003360
patient with IHD:@0.142546:0.941240:0.244684:0.941240:0.244684:0.927211:0.142546:0.927211:0.007956:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.003037:0.009179:0.009999
Initiated therapy at low dosage, usual starting dosage 12,5- 25 μg/day.:@0.376885:0.915584:0.837256:0.915584:0.837256:0.901555:0.376885:0.901555:0.003037:0.008198:0.002688:0.004556:0.002688:0.009179:0.004556:0.008735:0.009206:0.003723:0.004556:0.008198:0.008735:0.004045:0.009179:0.009165:0.007203:0.003723:0.009179:0.004556:0.003723:0.002688:0.008803:0.011168:0.003723:0.009206:0.008803:0.005214:0.009179:0.009045:0.008735:0.003723:0.003723:0.008171:0.005214:0.008171:0.009179:0.002688:0.003723:0.005214:0.004556:0.009179:0.004045:0.004556:0.002688:0.008198:0.009045:0.003723:0.009206:0.008803:0.005214:0.009179:0.009045:0.008735:0.003723:0.007445:0.007445:0.003723:0.007445:0.004462:0.003723:0.007445:0.007445:0.003723:0.008198:0.009045:0.005873:0.009206:0.009179:0.007203:0.003723
 :@0.837242:0.915584:0.840965:0.915584:0.840965:0.901555:0.837242:0.901555:0.003723
Increase 25 to 50 μg 4-6 weekly until TSH level normal.:@0.376885:0.928412:0.722391:0.928412:0.722391:0.914383:0.376885:0.914383:0.003037:0.008198:0.008695:0.004045:0.008735:0.009179:0.005214:0.008735:0.003723:0.007445:0.007445:0.003723:0.004556:0.008803:0.003723:0.007445:0.007445:0.003723:0.008198:0.009045:0.003723:0.007445:0.004462:0.007445:0.003723:0.011168:0.008735:0.008735:0.006746:0.002688:0.007203:0.003723:0.008171:0.008198:0.004556:0.002688:0.002688:0.003723:0.005725:0.006693:0.009179:0.003723:0.002688:0.008735:0.007445:0.008735:0.002688:0.003723:0.008198:0.008803:0.004045:0.012606:0.009179:0.002688:0.003723